274 related articles for article (PubMed ID: 10890909)
1. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis.
Wong ML; Xie B; Beatini N; Phu P; Marathe S; Johns A; Gold PW; Hirsch E; Williams KJ; Licinio J; Tabas I
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8681-6. PubMed ID: 10890909
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.
Marathe S; Kuriakose G; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2648-58. PubMed ID: 10559007
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
4. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
5. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
6. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling.
Marathe S; Schissel SL; Yellin MJ; Beatini N; Mintzer R; Williams KJ; Tabas I
J Biol Chem; 1998 Feb; 273(7):4081-8. PubMed ID: 9461601
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
Marathe S; Choi Y; Leventhal AR; Tabas I
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
[TBL] [Abstract][Full Text] [Related]
8. Secretory sphingomyelinase.
Tabas I
Chem Phys Lipids; 1999 Nov; 102(1-2):123-30. PubMed ID: 11001566
[TBL] [Abstract][Full Text] [Related]
9. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation.
Jenkins RW; Canals D; Idkowiak-Baldys J; Simbari F; Roddy P; Perry DM; Kitatani K; Luberto C; Hannun YA
J Biol Chem; 2010 Nov; 285(46):35706-18. PubMed ID: 20807762
[TBL] [Abstract][Full Text] [Related]
10. Elevated sphingomyelinase and hypercytokinemia in hemophagocytic lymphohistiocytosis.
Takahashi T; Abe T; Sato T; Miura K; Takahashi I; Yano M; Watanabe A; Imashuku S; Takada G
J Pediatr Hematol Oncol; 2002; 24(5):401-4. PubMed ID: 12142792
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
12. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, [corrected] TNF-α and IL-6 challenges in C57BL/6 mice.
Skelly DT; Hennessy E; Dansereau MA; Cunningham C
PLoS One; 2013; 8(7):e69123. PubMed ID: 23840908
[TBL] [Abstract][Full Text] [Related]
13. Lessons from interleukin-deficient mice: the interleukin-1 system.
Fantuzzi G
Acta Physiol Scand; 2001 Sep; 173(1):5-9. PubMed ID: 11678721
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages.
Barber SA; Detore G; McNally R; Vogel SN
Infect Immun; 1996 Aug; 64(8):3397-400. PubMed ID: 8757882
[TBL] [Abstract][Full Text] [Related]
15. Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice.
Wang W; Faubel S; Ljubanovic D; Mitra A; Falk SA; Kim J; Tao Y; Soloviev A; Reznikov LL; Dinarello CA; Schrier RW; Edelstein CL
Am J Physiol Renal Physiol; 2005 May; 288(5):F997-1004. PubMed ID: 15644489
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
17. Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells.
Falcone S; Perrotta C; De Palma C; Pisconti A; Sciorati C; Capobianco A; Rovere-Querini P; Manfredi AA; Clementi E
J Immunol; 2004 Oct; 173(7):4452-63. PubMed ID: 15383576
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
[TBL] [Abstract][Full Text] [Related]
19. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
20. Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways.
Netea MG; Kullberg BJ; Joosten LA; Sprong T; Verschueren I; Boerman OC; Amiot F; van den Berg WB; Van der Meer JW
Eur J Immunol; 2001 Sep; 31(9):2529-38. PubMed ID: 11536150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
